A Study Evaluating the Safety and Efficacy of Hormone Replacement Therapy With ST-1891 Compared to Levothyroxine in Patients With Primary Hypothyroidism

NCT05412979 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

490

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypothyroidism

Interventions

DRUG: ST-1891
DRUG: Levothyroxine

Sponsor

Sention Therapeutics, LLC